These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12419532)

  • 21. Determination of 1-methyl-1,2,3,4-tetrahydroisoquinoline in mouse brain after treatment with haloperidol by gas chromatography-selected ion monitoring.
    Igarashi K; Sugiyama Y; Kasuya F; Saiki K; Yamakawa T; Ohata S
    J Chromatogr B Biomed Sci Appl; 1999 Aug; 731(1):53-8. PubMed ID: 10491989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain.
    Kohno M; Ohta S; Hirobe M
    Biochem Biophys Res Commun; 1986 Oct; 140(1):448-54. PubMed ID: 3778459
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 24. Endogenous synthesis of N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of N-methylisoquinolinium ion, in the brains of primates with parkinsonism after systemic administration of 1,2,3,4-tetrahydroisoquinoline.
    Niwa T; Yoshizumi H; Tatematsu A; Matsuura S; Yoshida M; Kawachi M; Naoi M; Nagatsu T
    J Chromatogr; 1990 Nov; 533():145-51. PubMed ID: 2127934
    [No Abstract]   [Full Text] [Related]  

  • 25. Novel toxins and Parkinson's disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin.
    Naoi M; Maruyama W; Niwa T; Nagatsu T
    J Neural Transm Suppl; 1994; 41():197-205. PubMed ID: 7931227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism and penetration through blood-brain barrier of parkinsonism-related compounds. 1,2,3,4-Tetrahydroisoquinoline and 1-methyl-1,2,3,4-tetrahydroisoquinoline.
    Kikuchi K; Nagatsu Y; Makino Y; Mashino T; Ohta S; Hirobe M
    Drug Metab Dispos; 1991; 19(1):257-62. PubMed ID: 1673411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
    Naoi M; Maruyama W; Nagy GM
    Neurotoxicology; 2004 Jan; 25(1-2):193-204. PubMed ID: 14697894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of 1-methyl-1,2,3,4-tetrahydroisoquinoline against dopaminergic neurodegeneration in the extrapyramidal structures produced by intracerebral injection of rotenone.
    Antkiewicz-Michaluk L; Wardas J; Michaluk J; Romaska I; Bojarski A; Vetulani J
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):155-63. PubMed ID: 14741061
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antidopaminergic effects of 1,2,3,4-tetrahydroisoquinoline and salsolinol.
    Antkiewicz-Michaluk L; Michaluk J; Romańska I; Papla I; Vetulani J
    J Neural Transm (Vienna); 2000; 107(8-9):1009-19. PubMed ID: 11041279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tetrahydroisoquinolines in connection with Parkinson's disease].
    Ohta S
    Rinsho Shinkeigaku; 1989 Dec; 29(12):1504-6. PubMed ID: 2698297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzymatic oxidation of the dopaminergic neurotoxin, 1(R), 2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, into 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion.
    Naoi M; Maruyama W; Zhang JH; Takahashi T; Deng Y; Dostert P
    Life Sci; 1995; 57(11):1061-6. PubMed ID: 7658913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MPP(+) injection into rat substantia nigra causes secondary glial activation but not cell death in the ipsilateral striatum.
    Canudas AM; Friguls B; Planas AM; Gabriel C; Escubedo E; Camarasa J; Camins A; Pallàs M
    Neurobiol Dis; 2000 Aug; 7(4):343-61. PubMed ID: 10964606
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous risk factors in Parkinson's disease: dopamine and tetrahydroisoquinolines.
    Antkiewicz-Michaluk L
    Pol J Pharmacol; 2002; 54(6):567-72. PubMed ID: 12866710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline.
    Fuller RW; Hemrick-Luecke SK
    Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):519-22. PubMed ID: 6856953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.
    Antkiewicz-Michaluk L; Filip M; Michaluk J; Romańska I; Przegaliński E; Vetulani J
    J Neural Transm (Vienna); 2007 Mar; 114(3):307-17. PubMed ID: 16897599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
    Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
    Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opposite effect of simple tetrahydroisoquinolines on amphetamine- and morphine-stimulated locomotor activity in mice.
    Vetulani J; Nalepa I; Antkiewicz-Michaluk L; Sansone M
    J Neural Transm (Vienna); 2001; 108(5):513-26. PubMed ID: 11459073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinsonism produced by tetrahydroisoquinoline (TIQ) or the analogues.
    Yoshida M; Ogawa M; Suzuki K; Nagatsu T
    Adv Neurol; 1993; 60():207-11. PubMed ID: 8093578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of 1-phenyl-N-methyl-1,2,3,4-tetrahydroisoquinoline and 1-phenyl-1,2,3,4-tetrahydroisoquinoline in human brain by gas chromatography-tandem mass spectrometry.
    Kajita M; Niwa T; Fujisaki M; Ueki M; Niimura K; Sato M; Egami K; Naoi M; Yoshida M; Nagatsu T
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):345-51. PubMed ID: 7581910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-methyl(R)salsolinol, a dopamine neurotoxin, in Parkinson's disease.
    Naoi M; Maruyama W
    Adv Neurol; 1999; 80():259-64. PubMed ID: 10410730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.